she/her
Jill Rosenthal is the director of Public Health Policy at the Center for American Progress, where she works with other experts at CAP to develop and advance bold solutions to address structural public health issues and tackle health disparities through a social determinants of health framework. Before joining CAP, she served from 2000 to 2021 as senior program director at the National Academy for State Health Policy (NASHP), where she led NASHP’s population health portfolio, conducting research and policy analyses and providing technical assistance to states on identifying financial models to support population health improvement, building communities of practice, documenting best practices, and providing consultation as states developed models for nationwide spread. Rosenthal has a background in public health and health policy development, health promotion, and evaluation. She is a graduate of Colgate University and holds a master’s in public health from the University of North Carolina.
Jill Rosenthal explains why lapses in health data for COVID-19 reveal the fragility of the U.S. public health system.
Jill Rosenthal urges Congress to find a path forward on the $10 billion supplemental COVID-19 relief package.
Jill Rosenthal outlines next steps that the Biden administration, state and local policymakers, and private companies should take to prevent a winter surge in COVID-19 cases.
Jill Rosenthal discusses the efficacy of COVID-19 vaccine mandates.
Authors Jill Rosenthal and Ben Hatt commend the United States’ vaccine rollout and explain what must be done to ensure its continued success in the months ahead.
